Follow
Adam F. Maleki, MSc, Ph.D.
Adam F. Maleki, MSc, Ph.D.
Visiting Fellow
Verified email at nih.gov
Title
Cited by
Cited by
Year
Innate immune cells: Monocytes, monocyte-derived macrophages and microglia as therapeutic targets for alzheimer’s disease and multiple sclerosis
A Fani Maleki, S Rivest
Frontiers in cellular neuroscience 13, 355, 2019
782019
GAPDH, β-actin and β2-microglobulin, as three common reference genes, are not reliable for gene expression studies in equine adipose-and marrow-derived mesenchymal stem cells
F Nazari, A Parham, AF Maleki
Journal of animal science and technology 57, 1-8, 2015
452015
Development and use of quantitative competitive PCR assays for relative quantifying rumen anaerobic fungal populations in both in vitro and in vivo systems
MH Sekhavati, MD Mesgaran, MR Nassiri, T Mohammadabadi, F Rezaii, ...
mycological research 113 (10), 1146-1153, 2009
272009
Muramyl dipeptide-mediated immunomodulation on monocyte subsets exerts therapeutic effects in a mouse model of Alzheimer’s disease
A Fani Maleki, G Cisbani, MM Plante, P Préfontaine, N Laflamme, ...
Journal of Neuroinflammation 17, 1-12, 2020
212020
Introducing and validation of SYBR green real-time PCR method to determinate sex ratio in bovine semen
AF Maleki, ARH Moussavi, MR Nassiri, M Tahmoorespur, SA Vakili
Animal reproduction science 140 (1-2), 1-6, 2013
182013
Selective immunomodulatory and neuroprotective effects of a NOD2 receptor agonist on mouse models of multiple sclerosis
AF Maleki, G Cisbani, N Laflamme, P Prefontaine, MM Plante, ...
Neurotherapeutics 18 (2), 889-904, 2021
132021
Application of phiC31 integrase system in stem cells biology and technology: a review
A Fani Maleki, MH Sekhavati
Frontiers in Life Science 11 (1), 1-10, 2018
62018
Modulation of the innate immune system as a potential therapeutic strategy for Alzheimer's and Multiple Sclerosis Diseases
A Fani Maleki
2021
The system can't perform the operation now. Try again later.
Articles 1–8